DAMORA THERAPEUTICS, INC.

DMRA ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Feb 12, 2026 4
4 Feb 12, 2026 4
SCHEDULE 13D/A Feb 11, 2026
8-K Feb 11, 2026 8-K
424B5 Feb 11, 2026 424B5
424B5 Feb 10, 2026 424B5
S-3ASR Feb 10, 2026 S-3ASR
8-K Feb 10, 2026 8-K
4 Jan 26, 2026 4
3 Jan 26, 2026 3
SCHEDULE 13G Jan 12, 2026
SCHEDULE 13G Jan 12, 2026
8-K Jan 12, 2026 8-K
4 Jan 7, 2026 4
3 Jan 7, 2026 3
4 Jan 6, 2026 4
4 Jan 6, 2026 4
4 Jan 6, 2026 4
8-K Jan 6, 2026 8-K
S-8 Jan 2, 2026 S-8
DEF 14A Dec 31, 2025 DEF 14A
424B3 Dec 31, 2025 424B3
EFFECT Dec 23, 2025
CORRESP Dec 22, 2025
PRE 14A Dec 16, 2025 PRE 14A
← Newer Page 3 of 15 · 351 filings Older →